ArticleMikrochimica acta2026
AuNi alloy deposited heteroatom-doped porous carbon for the simultaneous detection of biogenic amines.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simultaneous determination of dopamine, serotonin, and melatonin was demonstrated using a disposable non-enzymatic electrochemical biosensor modified with AuNi alloy-deposited S, N-doped porous carbon. Initially, ZnO/S rich a S, N-doped carbon precursor was synthesized from Zn-rubeanic acid coordination polymer, followed by the acid treatment and pyrolysis under nitrogen to obtain S, N-doped porous carbon (SNPC). Then, a composite layer of benzoic acid functionalized polyterthiophene (pTBA) and SNPC was electrochemically formed (SNPC-pTBA) on the screen-printed electrode with additional subsequent casting of SNPC on the layer, followed by the deposition of AuNi nanoparticles (SNPC-pTBA/SNPC@AuNi) to further enhance the catalytic performance. To optimize the AuNi deposition conditions, the mole ratio, alloy deposition potential and time, SNPC content, and electrolyte pH were changed. Each sensing layer of the final sensor was characterized by electrochemical and surface analysis methods. Under the optimized condition, the proposed sensor exhibited well-defined oxidation peaks at 0.023 V, 0.182 V, and 0.40 V for dopamine, serotonin, and melatonin, respectively. The linear dynamic range was observed over the range 0.25 µM-500.0 µM, with detection limits of 65.8 ± 2.0 nM, 76.1 ± 1.3 nM, and 71.3 ± 2.7 nM for dopamine, serotonin, and melatonin, respectively. The sensor performance was almost unchanged in the presence of other interfering amines and non-amine molecules. The sensing platform reveals stability until 49 days with the relative standard deviation (RSD) of < 7.8%, and the sensor reliability was evaluated by detecting targeted biogenic amines in the real serum samples and the supplement tablet.
Indexed as
Identifiers
42215797What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.